Showing results (21-30 of 379) with videos related to
Sort By:
Pageof 38
Current Opinion in Cardiology|October 3, 2002
Aspirin in the prophylaxis of coronary artery diseasePaulette MehtaCurrent Opinion in Cardiology|August 12, 2005
C-reactive protein and cardiovascular disease: a critical appraisalJorge L Sepulveda, Jawahar L MehtaCurrent Opinion in Cardiology|October 3, 2002
Management of dyslipidemia in the primary prevention of coronary heart diseaseBalkrishna K Singh, Jawahar L MehtaArchives of Internal Medicine|June 11, 2003
Interactions between the renin-angiotensin system and dyslipidemia: relevance in the therapy of hypertension and coronary heart diseaseBalkrishna M Singh, Jawahar L MehtaJournal of Cardiovascular Pharmacology and Therapeutics|September 3, 2009
Rosuvastatin attenuates Ang II--mediated cardiomyocyte hypertrophy via inhibition of LOX-1Bum-Yong Kang, Jawahar L MehtaTherapeutic Advances in Cardiovascular Disease|October 23, 2010
Management of dyslipidemia in the elderly populationFreij A Gobal, Jawahar L MehtaCurrent Opinion in Cardiology|August 19, 2004
Potential of gene therapy for myocardial ischemiaPaul L Hermonat, Jawahar L MehtaThrombosis and Haemostasis|September 28, 2006
COX-2 inhibitors and cardiovascular risk. Inferences based on biology and clinical studiesMuhammad R Marwali, Jawahar L MehtaJournal of Cardiovascular Pharmacology and Therapeutics|October 20, 2020
Hypothesis: Sex-Related Differences in ACE2 Activity May Contribute to Higher Mortality in Men Versus Women With COVID-19Husam M Salah, Jawahar L MehtaExpert Review of Cardiovascular Therapy|July 1, 2016
Endothelial cell dysfunction as a novel therapeutic target in atherosclerosisHanna A Jensen, Jawahar L MehtaPageof 38